Smith Drug Co. v. Actavis (Namenda), No. 15-7488 (S.D.N.Y.)


In the Namenda case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Actavis’ memantine hydrochloride, sold under the brand name Namenda and Namenda XR.  The complaint alleges that Actavis engaged in an illegal product hop to move the market from Namenda to Namenda XR in order to thwart competition from generic Namenda.

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.

Details

Filed on 10/14/2015

Office

685 Third Avenue 26th Floor

10017 New York, New York

Phone (212) 983-9330

Fax (212) 983-9331

Counsel

Joseph T. Lukens jlukens@faruqilaw.com Phone (215) 277-5770 Fax (215) 277-5771

Peter Kohn pkohn@faruqilaw.com Phone (215) 277-5770 Fax (215) 277-5771

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885

Delaware

3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612

Georgia

3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania